Eur Rev Med Pharmacol Sci 2020; 24 (6): 2955-2964
DOI: 10.26355/eurrev_202003_20660

MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4

X.-L. Zhong, L. Wang, X. Yan, X.-K. Yang, H. Xiu, M. Zhao, X.-N. Wang, J.-X. Liu

Urinary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. beishijijie5725701@163.com


OBJECTIVE: Bladder cancer is the most frequent tumor of the urinary system. Despite variety of new treatment options, bladder cancer remains a main global medical problem. Our purpose was to explore the potential molecular and therapeutic targets of bladder cancer diagnosis.

PATIENTS AND METHODS: The qRT-PCR was used to assess the expression of miR-20a in tissues and cell lines. Counting Cell Kit-8 (CCK-8) assay was carried out to evaluate cell proliferation. Cell migration was calculated using the transwell assay.

RESULTS: The expression of miR-20a increased and PDCD4 decreased in bladder cancer tissues compared with normal tissues. Overexpression of miR-20a promoted T24 cell proliferation and migration, while miR-20a inhibitor suppressed cell proliferation and migration. MiR-20a targeted PDCD4 to regulate its expression in T24 cells. MiR-20a is inversely related to PDCD4 and PTENPL in bladder cancer tissues. Upregulation of PDCD4 suppressed T24 cell proliferation and migration.

CONCLUSIONS: The PTENP1/miR-20a/PTEN axis was involved in the progression of bladder cancer. Our study investigated the function of miR-20a in bladder cancer and provided new insights into the treatment of bladder cancer.

Free PDF Download

To cite this article

X.-L. Zhong, L. Wang, X. Yan, X.-K. Yang, H. Xiu, M. Zhao, X.-N. Wang, J.-X. Liu
MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 6
Pages: 2955-2964
DOI: 10.26355/eurrev_202003_20660